JG
CDNA icon

Joel Greenblatt’s CareDx CDNA Stock Holding History

Joel Greenblatt’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
73,579
-16,025
-18% -$349K ﹤0.01% 1128
2026
Q1 		$1.56M Buy
89,604
+7,011
+8% +$133K ﹤0.01% 1182
2025
Q4 		$1.56M Buy
+82,593
New +$1.38M 0.01% 1121
2024
Q4 		– Sell
-8,405
Closed -$262K – 1440
2024
Q3 		$262K Buy
+8,405
New +$209K ﹤0.01% 1277
2022
Q2 		– Sell
-8,774
Closed -$325K – 1134
2022
Q1 		$325K Sell
8,774
-19
-0.2% -$740 0.01% 929
2021
Q4 		$400K Sell
8,793
-184
-2% -$9.6K 0.01% 854
2021
Q3 		$569K Buy
8,977
+102
+1% +$7.77K 0.02% 626
2021
Q2 		$812K Sell
8,875
-49
-0.5% -$3.9K 0.03% 546
2021
Q1 		$608K Sell
8,924
-10,275
-54% -$798K 0.03% 627
2020
Q4 		$1.39M Sell
19,199
-1,251
-6% -$72.5K 0.05% 446
2020
Q3 		$776K Sell
20,450
-132
-0.6% -$4.46K 0.02% 618
2020
Q2 		$729K Buy
20,582
+1,141
+6% +$32.5K 0.02% 646
2020
Q1 		$424K Buy
+19,441
New +$436K 0.01% 748
2019
Q3 		– Sell
-22,855
Closed -$823K – 1101
2019
Q2 		$823K Buy
22,855
+10,097
+79% +$323K 0.01% 682
2019
Q1 		$402K Sell
12,758
-5,612
-31% -$163K 0.01% 916
2018
Q4 		$462K Buy
+18,370
New +$472K 0.01% 779

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Joel Greenblatt's CDNA Position: Q2 2026 in Review

Joel Greenblatt reduced its CareDx (CDNA) stake by 18% in Q2 2026, selling an estimated $349K and leaving 73,579 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Joel Greenblatt first reported a position in CDNA in Q4 2018 and has held it in 16 quarters since. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Joel Greenblatt held 73,579 shares of CareDx worth $2.1M as of Q2 2026.
  • Joel Greenblatt sold 16,025 CareDx shares in Q2 2026, an estimated $349K.
  • CareDx made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1128 holding.
  • Joel Greenblatt first reported a position in CareDx in Q4 2018 and has held it in 16 quarters since.
  • 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.